期刊文献+

重视合并肝切除在肝门胆管癌根治术中的地位 被引量:7

原文传递
导出
摘要 肝门部胆管癌(hilarcholan舀ocarcinoma)是指发生于胆囊管开口以上的肝总管及左右肝管的胆管癌,约占胆管癌的60%~70%,好发于50—70岁的中老年人。因Klatskin0lJ首先对胆管分叉部腺癌的病理特点进行描述,故又将肝门部胆管癌称为Klatskin瘤。肝门部胆管癌具有侵犯邻近肝脏、周围血管及神经,并发生淋巴结转移的特点,手术切除困难。手术切除是最有效和首选的治疗方法,而切缘无瘤是改善患者远期预后的重要因素。
出处 《中华普通外科杂志》 CSCD 北大核心 2013年第11期817-818,共2页 Chinese Journal of General Surgery
  • 相关文献

参考文献17

  • 1Klatskin G.Adenocarcinoma of the hepatic duct at its bifurcationwithin the portahepatis.An unusual tumor with distinctiveclinical and pathological features.Am J Med,1965,38:241-256.
  • 2Capussotti L,Vigano L,Ferrero A,et al.Local surgicalresection of hilar cholangiocarcinoma:is there still a place? HPB(Oxford),2008,10:174-178.
  • 3Ikeyama T,Nagino M,Oda K,et al.Surgical approach tobismuth Type I and II hilar cholangiocarcinoma:audit of 54consecutive cases.Ann Surg,2007,246:1052-1057.
  • 4Lim JH,Choi GH,Choi SH,et al.Liver resection for Bismuthtype I and Type II hilar cholangiocarcinoma.World J Surg,2013,37:829-837.
  • 5Lau SH,Lau WY.Current therapy of hilar cholangiocarcinoma.Hepatobiliary Pancreat Dis Int,2012,11:12-17.
  • 6Jamagin WR,Fong Y,DeMatteo RP,et al.Staging,resectability,and outcome in 225 patients with hilar cholangiocarcinoma.AnnSurg,2001,234:507-517.
  • 7Tsao JI,Nimura Y,Kamiya J,et al.Management of hilarcholangiocarcinoma:comparison of an American and a Japaneseexperience.Ann Surg,2000,232:166-174.
  • 8Lai EC,Lau WY.Aggressive surgical resection for hilarcholangiocarcinoma.ANZ J Surg,2005,75:981-985.
  • 9Matsuo K,Rocha FG,Ito K,et al.The Blumgart preoperativestaging system for hilar cholangiocarcinoma:analysis ofresectability and outcomes in 380 patients.J Am Coll Surg,2012,215:343-355.
  • 10Neuhaus P,Thelen A,Jonas S,et al.Oncological superiority ofhilar en bloc resection for the treatment of hilarcholangiocarcinoma.Ann Surg Oncol,2012,19:1602-1608.

同被引文献45

  • 1曹利平,蒋达峰,彭淑牖.肝叶切除术在肝门胆管癌手术中应用的价值[J].中华普通外科杂志,2006,21(3):161-163. 被引量:5
  • 2Dumitrascu T, Chirita D, Ionescu M, et al. Resection for hilar cholangiocarcinoma : analysis of prognostic factors and the impact of systemic inflammation on long-term outcome[J]. J Gastrointest Surg, 2013,17(5) :913-924.
  • 3Qiu J, Chen S, Pankaj P, Wu H. Portal Vein Arterializatinn as a Bridge Procedure Against Acute Liver Failure After Extended Hepatectomy for Hilar Cholangiocarcinoma [ J ]. Surg Innov, 2013,21 (4) :372-375.
  • 4Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality [ J ]. J Hepatobiliary Pancreat Sci. 2010.17(4):455-462.
  • 5Cho MS, Kim SH, Park SW, et ai. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma : 10-year single-institution experience [ J ]. J Gastrointest Surg, 2012,16(9) :1672-1679.
  • 6Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancers:application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization[ J]. Ann Surg, 2003,238:84-92.
  • 7Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report [ J ]. Surgery, 1990,107 : 521-527.
  • 8Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[ J]. Ann Surg, 2012, 255 ( 3 ) :405-414.
  • 9Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the international ALPPS registry[J]. Ann Surg, 2014,260(5) :836-838.
  • 10Petrowsky H,Gyori G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience [ J ]. Ann Surg, 2015,261 (4) :e90-92.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部